Clinical Trials Sponsored by Piramal Imaging Limited

Total 34 results

Piramal Imaging Limited

Completed

Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With AD

Alzheimer's Disease (AD)

France
Piramal Enterprises Limited

Completed

Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression (ENVER)

Melanoma

Australia, India, New Zealand
Piramal Enterprises Limited

Completed

A Phase IV Clinical Trial to Study the Safety, Tolerability and Efficacy of Tinefcon in Patients With Plaque Psoriasis

Plaque Psoriasis

India
Piramal Enterprises Limited

Completed

A Multicenter Phase I Clinical Study of a New Compound P1446A-05 in Patients With Advanced Refractory Malignancies

Cancer

Canada
Piramal Enterprises Limited

Terminated

A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States, India
Piramal Enterprises Limited

Withdrawn

Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma

Multiple Myeloma
Piramal Enterprises Limited

Terminated

Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms

Neoplasm

India
Viramal Limited

Completed

Exploratory Study on Two Different Doses of VML-0001 on the Effects on Vaginal pH in Healthy Post-Menopausal Women

Vaginal Atrophy

United States
Viramal Limited

Completed

Study to Determine Intraperitoneal,Tissue, Serum Concentrations of VML-0501 Following Five Days of Daily Vaginal Single Dose of VML-0501 (100 mg Danazol), in Comparison to Oral Danazol Capsules Daily 600 mg), in Women With Signs and Symptoms of Endometriosis Undergoing Laparoscopy

Endometriosis

Italy
Piramal Enterprises Limited

Completed

A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00

Radiation Induced Mucositis in Head and Neck Cancer

India
Piramal Enterprises Limited

Completed

A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer (MONARCH)

Squamous Cell Carcinoma of Head and Neck

India
Piramal Enterprises Limited

Terminated

Clinical Trial to Study the Safety Tolerability, Pharmacokinetics, Food Effect & Pharmacodynamics of a New Compound P7435 in Healthy, Overweight and/or Obese Subjects

Healthy, Overweight and/or Obese Subjects

India
Piramal Enterprises Limited

Terminated

Study of P3914 to Evaluate the Safety, Tolerability, Food Effect & Pharmacokinetics in Healthy Male Subjects and Efficacy & Safety of P3914 in Patients With Acute Dental Pain

Acute Dental Pain
Piramal Enterprises Limited

Completed

Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma

Relapsed and/or Refractory Multiple Myeloma

India
Piramal Enterprises Limited

Completed

Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer (SAVIOR)

Pancreatic Cancer

India
Piramal Enterprises Limited

Completed

Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms

Neoplasm

Canada, India
Piramal Enterprises Limited

Suspended

Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors

Advanced Refractory Solid Tumors

United States, India
Piramal Enterprises Limited

Suspended

Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors

Advanced Refractory Solid Tumors

United States, India
Piramal Enterprises Limited

Terminated

A Clinical Trial Comparing Gemcitabine and Carboplatin With and Without P276-00 in Subjects With Metastatic Triple Negative Breast Cancer, With a Run-in of Escalating Dose of P276-00 Added to Gemcitabine and Carboplatin

Breast Cancer

United States
Piramal Enterprises Limited

Terminated

A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes

Type 2 Diabetes Mellitus

Canada
Piramal Enterprises Limited

Completed

Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer (SPARK)

Squamous Cell Carcinoma of Head and Neck

India
Piramal Enterprises Limited

Completed

A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies (Serenity)

Solid Tumor | Hematologic Malignancy

India
Viramal Limited
Simbec Research

Recruiting

Study to Investigate the Pharmacokinetics & Safety Following One Application of 3 Different Doses 0.5,0.75,& 1.25 gm,a Transdermal Estradiol Cream (VML-0203), in Comparison to a Single Dose of EstroGel 1.25 gm to Healthy Post-menopausal Women.

Menopause

United Kingdom
Piramal Enterprises Limited
Melanoma Research Foundation Breakthrough Consortium

Suspended

Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation

Advanced or Inoperable Malignant Melanoma With BRAF Mutation

United States
Piramal Enterprises Limited
Quintiles, Inc.; Miami Research Associates

Unknown

Determination of Safety,Tolerability,Pharmacokinetics,Food Effect& Pharmacodynamics of Single & Multiple Doses of P11187

Overweight | Diabetes Mellitus Type 2 in Obese

United States
Quantum Imaging Limited

Completed

Magnetocardiography as a Tool for Patients Presenting With Chest Pain - Pilot Study

Chest Pain

United Kingdom
Piramal Enterprises Limited
Profil Institute for Clinical Research, Inc.

Completed

Study to Determine the Safety, Tolerability, Pharmacokinetics, Food Effect and Pharmacodynamics of Single and Multiple Ascending Doses of P7435 in Healthy, Overweight or Obese Subjects

Healthy

United States
Niramai Health Analytix Private Limited
Max Healthcare Insititute Limited

Completed

A Prospective Study to Evaluate Clinical Performance of Thermalytix in Detecting Breast Cancers

Breast Cancer | Early Detection of Cancer

India
Piramal Enterprises Limited
Dana-Farber Cancer Institute; Norris Cotton Cancer Center

Suspended

Clinical Study of Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

United States
Brigham and Women's Hospital
Nano-X Imaging Limited

Not yet recruiting

AI Detection of Incidental Coronary Artery Calcium to Enhance Cardiovascular Disease Prevention (AI INFORM)

Coronary Artery Disease

United States
Primal Therapies Inc.
Benjamin Rose Institute on Aging

Unknown

Evaluation of a Daily Oral Care Lozenge on Oral Health and Quality of Life in Older Adults

Oral Health

United States
KeifeRx, LLC
Worldwide Clinical Trials; Life Molecular Imaging GmbH; Sun Pharmaceuticals Industries...

Not yet recruiting

Evaluating the Efficacy and Safety of Nilotinib BE in Subjects With Early Alzheimer's Disease (NILEAD)

Alzheimer Disease
University of Oxford
British Heart Foundation; European Commission; Oxford University Hospitals NHS... and other collaborators

Recruiting

The Oxford Risk Factors And Non-Invasive Imaging Study (ORFAN)

Cardiovascular Diseases | Cardiovascular Risk Factors

United Kingdom, Germany, Belgium, China, United States, Australia, France, Greece, Hungary, Italy, Japan, Korea, Republic of, Netherlands, Romania, United Arab Emirates
Fondazione del Piemonte per l'Oncologia
National Cancer Institute (NCI); University of Pisa; Royal Marsden NHS Foundation... and other collaborators

Recruiting

An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum

Prostate Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic | Prostate Cancer Aggressiveness

Italy

3

Subscribe